Role for PP2A in ARF signaling to p53

Proceedings of the National Academy of Sciences of the United States of America
M G MouleM Fried

Abstract

Activation of the ARF-p53 tumor suppressor pathway is one of the cell's major defense mechanisms against cancer induced by oncogenes. The ARF-p53 pathway is dysfunctional in a high proportion of human cancers. The regulation of the ARF-p53 signaling pathway has not yet been well characterized. In this study polyoma virus (Py) is used as a tool to better define the ARF-p53 signaling pathway. Py middle T-antigen (PyMT) induces ARF, which consequently up-regulates p53. We show that Py small T-antigen (PyST) blocks ARF-mediated activation of p53. This inhibition requires the small T-antigen PP2A-interacting domain. Our results reveal a previously unrecognized role of PP2A in the modulation of the ARF-p53 tumor suppressor pathway.

References

Apr 1, 1991·Molecular and Cellular Biology·S I YangM C Mumby
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G WalterM Mumby
Jan 28, 1998·Oncogene·O MorM Fried
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·T KamijoC J Sherr
Mar 11, 1999·Current Opinion in Genetics & Development·N E Sharpless, R A DePinho
May 14, 1999·Trends in Biochemical Sciences·T A MillwardB A Hemmings
Feb 19, 2000·Current Opinion in Genetics & Development·C J Sherr, J D Weber
Sep 29, 2000·Biochemical Pharmacology·S Zolnierowicz
Mar 10, 2001·Experimental Cell Research·D B Woods, K H Vousden
Mar 21, 2001·Cellular Signalling·E Sontag
May 2, 2001·Nature Cell Biology·S LlanosG Peters
Aug 30, 2001·Oncogene·M Lomax, M Fried
Oct 5, 2001·Nature Reviews. Molecular Cell Biology·C J Sherr
Dec 12, 2001·Molecular and Cellular Biology·Chandrashekhar KorgaonkarDawn E Quelle
Dec 26, 2001·Oncogene·N Ichaso, S M Dilworth
Mar 9, 2002·Molecular and Cellular Biology·William C HahnRobert A Weinberg
Sep 3, 2002·Cancer Cell·Charles J Sherr, Frank McCormick
Jul 25, 2003·Trends in Biochemical Sciences·Harumi Shimizu, Ted R Hupp
Jan 28, 2004·Cell·Charles J Sherr

❮ Previous
Next ❯

Citations

Dec 2, 2008·Nature Reviews. Drug Discovery·Alexei VazquezGareth L Bond
Nov 22, 2005·Oncogene·Jason D Arroyo, William C Hahn
Nov 22, 2005·Oncogene·Clodagh C O'Shea
Sep 2, 2009·Microbiology and Molecular Biology Reviews : MMBR·Michele M Fluck, Brian S Schaffhausen
Dec 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Pablo Rodriguez-VicianaMike Fried
Sep 24, 2013·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·Xiuqiu GaoMing Zhong
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Rubaiyat Rahman-RoblickKlas G Wiman
Nov 10, 2010·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Horng D OuClodagh C O'Shea
Jul 30, 2010·International Journal of Cancer. Journal International Du Cancer·Alexei VazquezKim M Hirshfield
Jan 22, 2005·Current Opinion in Genetics & Development·Clodagh C O'Shea
Oct 8, 2005·Seminars in Oncology·Marcella MacalusoAntonio Giordano
Jul 8, 2014·Oncogene·A T Pores FernandoT M Roberts
Jul 17, 2007·Cell·Melissa R JunttilaJukka Westermarck
Jan 1, 2010·Viruses·Carmen RivasCesar Munoz-Fontela
Nov 21, 2007·Journal of Cellular Physiology·Kamel KhaliliMahmut Safak
Sep 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lukasz F GrocholaGareth L Bond

❮ Previous
Next ❯

Related Concepts

Related Feeds

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.